#Giving Tuesday is December 3!

INDIVIDUALS LIVING WITH SCD IN THE U.S.

HOSPITALIZATIONS ANNUALLY DUE TO SCD IN THE U.S.

NEW DRUG APPROVED BY FDA IN LAST 20 YEARS

NEW DRUGS CURRENTLY IN PHASE III CLINICAL TRIALS